Marker Therapeutics Inc (MRKR)

[microcapbiotech]

I don't want to belabor the point, but I have been thinking about this "worth" subject and it seems to me that there is an unfairness, a nonrecognition componant, and a need for a kickback system in this whole "worth" issue.
Hypothetically, let's just say that Marker or someone else comes up with a cure for 2 or 3 or 4 types of cancer.
Everyone chants Yeah Great, the combined cancer market for those "cures" is 5 billion, Marker or another gets half the market, Yeah Great, there are worth 2.5 billion.

What's unfair about that?
What componant is not being recognized?
Who should be giving kickbacks?
How many BILLIONS of dollars will be saved because of not having to spend them by Medicaid and Medicare and private insurance companies for non-needed treatments? Which is a savings for all American citizens.
How many Hundreds of Millions of dollars will be saved by insurance companies who no longer are paying death benefits to cancer survivors (yet), who will now be able to continue to collect premiums for many more years and decades?

I know, blah blah blah, none of this concerns or is factored into a companies market cap.
There just seems to be an unequity aspect that will never be rewarded that just doesn't sit right with me.